We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$339B
AUM Growth
+$32.7B
Cap. Flow
+$7.03B
Cap. Flow %
2.08%
Top 10 Hldgs %
18.14%
Holding
3,647
New
148
Increased
2,572
Reduced
501
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 21.96%
2 Financials 12.71%
3 Healthcare 11.98%
4 Consumer Discretionary 10.85%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OIG
3501
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$57K ﹤0.01%
647
CLSD
3502
DELISTED
Clearside Biomedical
CLSD
$56K ﹤0.01%
1,348
EPM icon
3503
Evolution Petroleum
EPM
$131M
$56K ﹤0.01%
+11,036
New +$61.2K
STSA
3504
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$56K ﹤0.01%
12,319
MCHX icon
3505
Marchex
MCHX
$78M
$55K ﹤0.01%
22,111
FBRX icon
3506
Forte Biosciences
FBRX
$1.58B
$54K ﹤0.01%
992
-143
-13% -$9.62K
SVRA icon
3507
Savara
SVRA
$1.14B
$54K ﹤0.01%
42,882
APTX
3508
DELISTED
Aptinyx Inc. Common Stock
APTX
$54K ﹤0.01%
+20,000
New +$48.1K
HIL
3509
DELISTED
Hill International, Inc. Common Stock
HIL
$54K ﹤0.01%
27,687
ZYNE
3510
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$53K ﹤0.01%
18,093
CHRA
3511
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$53K ﹤0.01%
1,109
MLSS icon
3512
Milestone Scientific
MLSS
$34.6M
$52K ﹤0.01%
24,916
CFRX
3513
DELISTED
ContraFect Corporation
CFRX
$52K ﹤0.01%
246
CBIO
3514
Crescent Biopharma
CBIO
$555M
$51K ﹤0.01%
349
LPCN icon
3515
Lipocine
LPCN
$17.4M
$50K ﹤0.01%
+2,941
New +$54.6K
VNRX icon
3516
VolitionRx Ltd
VNRX
$9.63M
$49K ﹤0.01%
769
WMC
3517
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$49K ﹤0.01%
2,307
MNOV icon
3518
MediciNova
MNOV
$66M
$48K ﹤0.01%
17,843
WATT icon
3519
Energous
WATT
$77.2M
$48K ﹤0.01%
63
SUP
3520
DELISTED
Superior Industries International
SUP
$47K ﹤0.01%
10,350
WTER
3521
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$47K ﹤0.01%
2,653
BCLI
3522
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$46K ﹤0.01%
752
CASI
3523
DELISTED
CASI Pharmaceuticals
CASI
$44K ﹤0.01%
5,406
PANL icon
3524
Pangaea Logistics
PANL
$493M
$44K ﹤0.01%
11,475
ENZ
3525
DELISTED
Enzo Biochem, Inc.
ENZ
$44K ﹤0.01%
13,471

Similar funds

Charles Schwab's Q4 2021 Portfolio in Review

As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
  • Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
  • Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
  • Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
  • Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
  • Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
  • Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.

Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.